A nurse is reviewing a client’s laboratory results and sees that their hemoglobin A1C is 9. Which of the following statements from the nurse is appropriate?

Choice A reason: Acetone Breath

Acetone breath is typically associated with diabetic ketoacidosis (DKA), not hyperosmolar hyperglycemic syndrome (HHS). In DKA, the body produces high levels of ketones, leading to a fruity or acetone-like breath odor. HHS, on the other hand, does not usually involve significant ketone production, so acetone breath is not a characteristic feature of HHS.

Choice B reason: Fever

Fever can be a clinical manifestation of HHS, often indicating an underlying infection, which is a common precipitating factor for HHS. Infections can exacerbate hyperglycemia and contribute to the development of HHS, making fever a relevant symptom to consider.

Choice C reason: 68 Years of Age

While age itself is not a clinical manifestation, HHS predominantly affects older adults, particularly those with type 2 diabetes. Therefore, being 68 years old is consistent with the typical demographic affected by HHS, but it is not a direct clinical manifestation.

Choice D reason: Serum Glucose 800 mg/dL

A serum glucose level of 800 mg/dL is significantly elevated and is a hallmark of HHS2. Normal serum glucose levels range from 74 to 106 mg/dL. Such high levels of glucose are indicative of severe hyperglycemia, which is a defining characteristic of HHS.

Choice E reason: Serum Bicarbonate 15 mEq/L

A serum bicarbonate level of 15 mEq/L is below the normal range of 21 to 28 mEq/L. This indicates metabolic acidosis, which can occur in HHS due to severe dehydration and impaired renal function. Although metabolic acidosis is more pronounced in DKA, it can still be present in HHS.

Choice F reason: Insidious Onset

HHS typically has an insidious onset, developing slowly over days to weeks. This gradual progression contrasts with the rapid onset of DKA and is a key feature in the clinical presentation of HHS.

Choice A Reason:

Conivaptan hydrochloride is a vasopressin receptor antagonist used to treat hyponatremia in patients with SIADH. It works by blocking the action of vasopressin, thereby promoting water excretion without significant loss of sodium. This helps to correct the water imbalance caused by SIADH. Conivaptan is typically administered intravenously and is effective in increasing serum sodium levels.

Choice B Reason:

Vasopressin, also known as antidiuretic hormone (ADH), is contraindicated in patients with SIADH because it exacerbates the condition. SIADH is characterized by excessive release of ADH, leading to water retention and hyponatremia. Administering vasopressin would further increase water reabsorption in the kidneys, worsening the hyponatremia.

Choice C Reason:

Sodium chloride tablets are used to manage hyponatremia in SIADH by increasing sodium intake. This helps to counteract the dilutional hyponatremia caused by excessive water retention. Sodium chloride tablets are often prescribed alongside fluid restriction to help raise serum sodium levels.

Choice D Reason:

Tolvaptan is another vasopressin receptor antagonist used to treat hyponatremia in SIADH. It works similarly to conivaptan by blocking the action of vasopressin, promoting water excretion, and increasing serum sodium levels. Tolvaptan is typically administered orally and is effective in managing SIADH.